Anti-infection
-
BA1892 JTK-109Summary: JTK-109 is a potent inhibitor of hepatitis C virus RNA-dependent RNA polymerase. - BA1895 ABBV-744Summary: ABBV-744 is a first-of-its-kind, orally active and selective BDII structural domain of the BET family of proteins.
- BA1896 BictegravirSummary: Bictegravir (GS-9883) is a potent integrase inhibitor.
- BA1897 CenicrivirocSummary: Cenicriviroc (TAK-652) is an orally available dual antagonist.
- BA1898 TAK-779Summary: TAK-779 is a potent, selective, non-peptide and antagonist.
- BA1899 FangchinolineSummary: Fangchinoline has a wide range of biological activities such as immune-enhancing, anti-inflammatory and antiseptic, and anti-atherosclerotic.
- BA1902 Ro24-7429Summary: Ro24-7429 is a potent and orally active HIV-1 trans-activator protein antagonist.
- BA1903 BRD-6929Summary: BRD-6929 is a class I histone deacetylase and brain permeability selective inhibitor.
- BA1904 MitoguazoneSummary: Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbony derivative with potent antitumor activity.
- BA1908 MS417Summary: MS417 is a selective inhibitor of BET-specific proteins.